Orum Therapeutics IPO Valuation Analysis
Our base case target price for Orum Therapeutics is 35,170 won per share, which is within the IPO price range of 30,000 won to 36,000 won per share.
Given the lack of upside relative to the target price, we have a Negative View of this IPO.
FSS has requested correction to the company's IPO prospectus. As a result, it now appears the IPO could be delayed.
Keep reading with a 7-day free trial
Subscribe to Douglas Research Insights to keep reading this post and get 7 days of free access to the full post archives.